Enzymotec Ltd. (ENZY) Analysts See $0.05 EPS; Last Week Superconductor Technologies Inc. (SCON) Coverage

February 18, 2018 - By Adrian Erickson

Analysts expect Enzymotec Ltd. (NASDAQ:ENZY) to report $0.05 EPS on February, 28.They anticipate $0.18 EPS change or 138.46% from last quarter’s $-0.13 EPS. ENZY’s profit would be $1.17M giving it 59.25 P/E if the $0.05 EPS is correct. After having $0.04 EPS previously, Enzymotec Ltd.’s analysts see 25.00% EPS growth. It closed at $11.85 lastly. It is up 10.01% since February 18, 2017 and is uptrending. It has underperformed by 6.69% the S&P500.

Among 3 analysts covering Superconductor (NASDAQ:SCON), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Superconductor had 4 analyst reports since September 25, 2015 according to SRatingsIntel. The rating was downgraded by Ladenburg Thalmann to “Neutral” on Friday, September 25. The rating was upgraded by Ladenburg Thalmann to “Buy” on Wednesday, November 11. H.C. Wainwright maintained Superconductor Technologies Inc. (NASDAQ:SCON) rating on Friday, August 11. H.C. Wainwright has “Buy” rating and $300 target. As per Thursday, April 6, the company rating was upgraded by Rodman & Renshaw. See Superconductor Technologies Inc. (NASDAQ:SCON) latest ratings:

Superconductor Technologies Inc. develops and commercializes high temperature superconductor materials and related technologies in the United States. The company has market cap of $12.54 million. It is involved in developing Conductus wire products for superconducting high power transmission cable, superconducting fault current limiters, and high field magnet applications. It currently has negative earnings.

The stock increased 0.85% or $0.0099 during the last trading session, reaching $1.1699. About 75,752 shares traded. Superconductor Technologies Inc. (NASDAQ:SCON) has declined 36.86% since February 18, 2017 and is downtrending. It has underperformed by 53.56% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts